AIM ImmunoTech Inc.
- Last sale
- Nov 12, 2026 · -0.48%
- Market cap
- $5.83M
- 39.92M shares
- Filings
- 1,040
Q3 2026−48.2% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q3 2026N/M FY25 yoy
Q3 2026+75.5% FY25 yoy
- $5.83M
- —
- 64.0×
- 0.8×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $88,000 | reported | |
| FY 2024 | 2024-12-31 | $170,000 | reported | |
| FY 2023 | 2023-12-31 | $202,000 | reported | |
| FY 2022 | 2022-12-31 | $141,000 | reported | |
| FY 2021 | 2021-12-31 | $135,000 | reported | |
| FY 2020 | 2020-12-31 | $163,000 | reported | |
| FY 2019 | 2019-12-31 | $140,000 | reported | |
| FY 2018 | 2018-12-31 | $367,000 | reported | |
| FY 2017 | 2017-12-31 | $437,000 | reported | |
| FY 2016 | 2016-12-31 | $92,000 | reported | |
| FY 2015 | 2015-12-31 | $133,000 | reported | |
| FY 2014 | 2014-12-31 | $197,000 | reported |
Segments
LineFY2020ShareChange
United States$144.00K88%+30.9%
Europe$19.00K12%−36.7%
Total$163.00K
Biological products, except diagnostic substances
AIM ImmunoTech Inc. is the 85th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
PROKProkidney Corp.$893.0K1,075.0%7,725.2%$347.7MIMAImageneBio, Inc.$800.0K77.1%5,668.6%$45.0MCRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MATYRaTYR PHARMA INC$190.0K19.1%39,009.5%$16.3MVIVSVivoSim Labs, INC.$131.0K9.0%10,567.2%$2.8M
AIMAIM ImmunoTech Inc. (this company)$88.0K48.2%15,861.4%$5.8M
INMBInmune Bio, Inc.$50.0K257.1%91,866.0%$32.2MENTXEntera Bio Ltd.$42.0K76.8%27,235.7%$559.9MSNTISenti Biosciences Holdings, Inc.$22.0K—279,263.6%$4.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
AIM ImmunoTech Inc. · CIK 946644 · Engraved from SEC EDGAR